NEW YORK (GenomeWeb News) – Through the first six months of 2012, the number of mergers and acquisitions in the 'omics-related tools and molecular diagnostics markets fell nearly 30 percent compared to a year ago, though a few big deals focused on diagnostics were consummated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.